In conclusion, our results suggest that PRMT7 is involved in the tumorigenesis and progression of GC and inhibits the proliferation and migration of GC cells by binding to PTEN to promote its methylation modification, thereby regulating the downstream PI3K/AKT signaling pathway. Here, PRMT7 is linked to gastric cancer.